PR Newswire09.04.20
Respiratory Motion Inc. (RMI) has appointed Chas Taylor and Bob Smouse, M.D., FACR to the Board of Directors. Taylor has been named board chairman and Smouse, the company president, will oversee day to day operations.
"The RMI ExSpiron is a technology that can save lives for patients across many care areas in the hospital," said Dr. Smouse. "In my years of clinical practice, I have rarely seen technologies that can become the new standard of care like the RMI system. I am excited to play a role in bringing this groundbreaking technology to clinicians and patients."
Dr. Smouse was most recently the founder, CEO, and chief medical officer of BrightWater Medical, a medical device company that developed a urologic and biliary stent technology that was acquired by Merit Medical in 2019. Dr. Smouse has served as a medical consultant and Scientific Advisory Board member for many medical device industry leaders. In addition to his commercial activity, Dr. Smouse has more than 25 years clinical experience in interventional radiology including leading academic training programs and many important clinical research studies.
"RMI has groundbreaking technology that will create a new category of respiratory monitoring," said Taylor. "I see this as an opportunity to build a strong successful business by introducing products that save costs and improve patient outcomes."
Taylor has over 30 years of experience in the medical technology industry. Recently he was the CEO of Veryan Medical, a co-founder and executive chairman of Novate Medical, and a director of BrightWater. All three companies were acquired in the last three years. Previously, Taylor was the co-founder and president of MedNova, which was acquired by Abbott Laboratories. Prior to founding and leading these companies, he had a long career with C.R. Bard, where he had various leadership responsibilities.
"We are delighted to have Chas and Bob join the Board of Directors at Respiratory Motion," said Jaideep Mehta, M.D., MBA, FASA, board member and previous chairman. "They bring a track record of success and experience that will help Respiratory Motion grow and thrive."
"The RMI ExSpiron is a technology that can save lives for patients across many care areas in the hospital," said Dr. Smouse. "In my years of clinical practice, I have rarely seen technologies that can become the new standard of care like the RMI system. I am excited to play a role in bringing this groundbreaking technology to clinicians and patients."
Dr. Smouse was most recently the founder, CEO, and chief medical officer of BrightWater Medical, a medical device company that developed a urologic and biliary stent technology that was acquired by Merit Medical in 2019. Dr. Smouse has served as a medical consultant and Scientific Advisory Board member for many medical device industry leaders. In addition to his commercial activity, Dr. Smouse has more than 25 years clinical experience in interventional radiology including leading academic training programs and many important clinical research studies.
"RMI has groundbreaking technology that will create a new category of respiratory monitoring," said Taylor. "I see this as an opportunity to build a strong successful business by introducing products that save costs and improve patient outcomes."
Taylor has over 30 years of experience in the medical technology industry. Recently he was the CEO of Veryan Medical, a co-founder and executive chairman of Novate Medical, and a director of BrightWater. All three companies were acquired in the last three years. Previously, Taylor was the co-founder and president of MedNova, which was acquired by Abbott Laboratories. Prior to founding and leading these companies, he had a long career with C.R. Bard, where he had various leadership responsibilities.
"We are delighted to have Chas and Bob join the Board of Directors at Respiratory Motion," said Jaideep Mehta, M.D., MBA, FASA, board member and previous chairman. "They bring a track record of success and experience that will help Respiratory Motion grow and thrive."
